Search published articles


Showing 2 results for Echinococcus Granulosus
Effects of Methanolic Extract of Ficus carica Leaves on Cystic Echinococcosis
Jaber Ali Poor , Mansor Dabirzadeh, Yahya Marofi , Seyed Ali Asghar Sefidgar,
Volume 11, Issue 3 (5-2017)
Abstract
ABSTRACT
          Background and objective: Surgery is the gold standard treatment for hydatidosis. Scolicidal agents could be used during surgery to kill protoscoleces and prevent cyst recurrence after rupturing of main lesion. Non-chemical agents with sufficient protoscolex-killing activity are known to be fully effective in this regard with fewer side effects. Fig tree is an Iranian native plant, which has been used for medicinal purposes in traditional medicine.
          Methods: After obtaining infected hydatid cyst of the liver from a slaughterhouse in Babol (Iran), the percentage of live protoscoleces was calculated by critical staining with 0.1 % eosin. Then, the protoscolex-killing activity of methanolic extract of fig leaves was evaluated at concentrations of 2.5, 5, 10, 15 and 20 mg/ml in 2, 4, 8, 12, and 16 minutes exposure times. Statistical analysis was performed using SPSS software (version 22).
          Results: Concentration of 20 mg/ml of the extract showed 100% protoscolex-killing activity within the first 2 minutes of exposure. In addition, the lowest protoscolex-killing activity (45%) was observed at concentration of 2.5 mg/ml after 2 minutes. The results also showed that the protoscolex-killing activity of the extract increases significantly in a concentration- and time-dependent manner (P <0.001).
         Conclusion: The methanolic extract of fig leaf at concentration of 20 mg/ml could exert significant scolicidal effect within 2 minutes of exposure. Therefore, complementary experiments should be performed on animal models to further assess the efficiency of the extract for killing protoscoleces of hydatid cyst during surgery.
          Keywords: Echinococcus granulosus, methanolic extract of Ficus carica, broth dilution. 

In Vitro Protoscolicidal Activity of Pomegranate (Punica Granatum) Rind and Barberry (Berberis Vulgaris) Alcoholic Extracts against Hydatid Cysts Caused by Echinococcus granulosus
Shahab Shiri Hamedani, Mohsen Mansouri, Sina Shiri Hamedani, Parham Tadayon, Peyman Aslani, Mohammad Mohsen Homayouni,
Volume 16, Issue 4 (7-2022)
Abstract
Background and objectives: Echinococcosis is a global cosmopolitan zoonotic disease and a major veterinary and public health issue. In humans, echinococcosis usually develops following close contact with infected dogs or ingestion of the parasite eggs. Until now, no effective vaccine has been commercially developed, and treatment is only focused on controlling hydatidosis. This study was conducted to evaluate the protoscolicidal activity of alcoholic extracts of pomegranate rind and barberry.
Methods: The alcoholic extracts of pomegranate rind and barberry were prepared by mixing 330 g of powdered plants with 1,000 ml of 70% ethanol. A concentrate of viable protoscolices (PCSs) was obtained from hydatid cysts found in the lungs and liver of sheep. Next, PCSs were treated with four different concentrations (5, 10, 20, 30, and mg/ml) of each extract for 10, 20, 30, and 60 minutes. The eosin exclusion test was performed to assess viability of the PCSs.
Results: The mortality rate caused by treatment with the extracts ranged between 25% and 100%. Complete inactivation of PCSs was achieved after 60 minutes of exposure to 15 mg/ml of the pomegranate rind extract and 30 mg/ml of the barberry extract.
Conclusion: Given their favorable anti-PCSs activity, combination of conventional synthetic albendazole with the alcoholic extracts of pomegranate rind and barberry might induce higher anti-PCS activity with lower side effects. It is recommended to evaluate the anti-PCSs activities of the pomegranate rind and barberry alcoholic extracts in vivo and ex vivo.
Page 1 from 1     

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.